.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Bovine mastitis remains a significant challenge for the global dairy industry, causing substantial economic losses and welfare concerns. Currently, clinicians and veterinarians rely heavily on antibiotic therapy to manage these infections. However, this dependence has led to the rise of antibiotic-resistant bacteria and concerning drug residues in milk. Consequently, researchers are actively seeking alternative therapies. Recent evidence suggests that Fisetin for mastitis treatment could serve as a potent, natural alternative due to its robust antioxidant and anti-inflammatory properties.
Fisetin (FIS) is a flavonoid found naturally in various fruits and vegetables like strawberries and apples. In a recent study using lipopolysaccharide (LPS)-induced models, researchers investigated how this compound regulates oxidative stress. Specifically, the results demonstrated that FIS effectively reduces inflammatory cytokines in mammary tissues. By modulating cellular pathways, Fisetin offers a multi-targeted approach to resolving inflammation without the risks associated with traditional antimicrobials.
A primary highlight of the research is the role of FIS in inhibiting ferroptosis. Ferroptosis is a form of regulated cell death characterized by iron overload and lipid peroxidation. During mastitis, LPS triggers oxidative damage that leads to this iron-dependent cell death, further compromising the blood-milk barrier. The study utilized western blot and tissue iron analysis to confirm that FIS treatment reverses these effects. Therefore, by preventing ferroptosis, FIS helps maintain the structural integrity of mammary epithelial cells during an inflammatory challenge.
Beyond direct tissue protection, Fisetin appears to influence the gut-mammary axis. The researchers employed gut microbiota sequencing and metabolomics to observe the systemic effects of FIS. Interestingly, FIS treatment altered the gut microbiota structure in mice, leading to a significant increase in short-chain fatty acids (SCFAs). These metabolites play a crucial role in systemic health and systemic anti-inflammatory responses. Moreover, the restoration of a healthy microbial balance contributed to the repair of the blood-milk barrier, which is often damaged during acute mastitis episodes.
Furthermore, the study suggests that these traditional medicine-based strategies could revolutionize how we approach mammary infections. By focusing on host resilience and microbial health rather than just pathogen elimination, FIS provides a sustainable therapeutic model. As a result, this natural compound may eventually offer a safer, non-toxic clinical strategy for both veterinary and potentially human applications in the future.
Fisetin helps by inhibiting ferroptosis, a type of cell death caused by iron accumulation and oxidative stress. Additionally, it reduces the levels of pro-inflammatory cytokines and helps restore the blood-milk barrier by modulating the gut microbiota.
The gut microbiota influences mammary health through the gut-mammary axis. Beneficial bacteria produce short-chain fatty acids (SCFAs) that strengthen systemic immunity and help repair damaged barriers in the mammary glands.
While FIS shows great potential as a non-antibiotic alternative in experimental models, further clinical trials are necessary to determine its efficacy as a standalone replacement for antibiotics in commercial or clinical settings.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical or veterinary advice. Refer to the latest local and national guidelines for clinical practice.
References
Tong C et al. Fisetin alleviates lipopolysaccharide-induced mastitis by inhibiting ferroptosis and modulating the gut microbiota. Vet Q. 2026 Dec undefined. doi: 10.1080/01652176.2026.2642789. PMID: 41844527.
Jiang J et al. Fisetin Ameliorates the Inflammation and Oxidative Stress in Lipopolysaccharide-Induced Endometritis. J Inflamm Res. 2021;14:2963-2978. doi: 10.2147/JIR.S314130.
Ashiqueali S et al. Fisetin modulates the gut microbiota alongside biomarkers of senescence and inflammation in a murine model. GeroScience. 2024;46:95-110. doi: 10.1007/s11357-023-00987-x.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Fisetin (FIS) shows promise in treating mastitis by inhibiting ferroptosis and restoring gut microbiota, offering a potential alternative to antibiotics....
5 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
